The decision was disclosed in a worker adjustment and retraining notification filed by the company, which makes nutrition protein therapies for malnourished dialysis patients.
The job cuts will be effective Jan. 4.
Pentec’s other sites in Boothwyn and Glen Mills, Pa. will remain open, and it will continue its 503A operations, according to the Philadelphia Business Journal.
Read the full article here.
More articles on pharmacy:
Drugmakers could lose $1T in sales and still be most profitable industry, analysis finds
CAR-T costs ‘not sustainable’ for hospitals, researchers say
How Walgreens, CVS see the future of pharmacy
